Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs Microdosing

Psychedelic microdosing doesn’t actually help people open up emotionally, study suggests

by Eric W. Dolan
February 26, 2023
in Microdosing
Share on TwitterShare on Facebook
Follow PsyPost on Google News

The practice of “microdosing” appears to result in a decrease in emotional diversity, according to new research published in the Journal of Psychedelic Studies.

Microdosing involves taking very small amounts of a psychedelic substance, such as LSD or psilocybin, in order to experience its subtle effects without inducing a full-blown psychedelic experience. Some people use microdosing to attempt to alleviate symptoms of depression and anxiety but others view it as a tool for self-enhancement.

The idea is that this small amount of the substance can enhance creativity, focus, and mood, and potentially offer other benefits without the hallucinogenic effects associated with higher doses. But most of the supposed benefits of microdosing are based on anecdotal reports.

“In light of the resurgence of psychedelics in clinical treatment of mental disorders, a lot of focus has shifted to psychopathology and large dose psychedelics. Still, many people don’t suffer from mental health issues and want to use microdosing to enhance their cognitive and emotional functions,” said Ioana Pop, an assistant professor at Tilburg University.

“Even though there’s a lot of personal experience, there’s been little scientific research, especially since everyone does it differently, using different substances and protocols. The goal was to understand how microdosing actually works in the real world, so people can manage their expectations.”

“Research on the emotional effects of psychedelics has a lot of interesting lines of inquiry that imply a broader emotional experience,” Pop explained. “We were interested in zooming in on this emotional opening process. The concept of emotional diversity points us toward just that, a broader range of emotions experienced with similar intensity throughout the day.”

The researchers collected information from 18 people over 28 days to investigate the effects of microdosing on emotional diversity. At the beginning of the study, participants were asked about their personal information and history of substance use. The researchers used a smartphone app to prompt participants at various points during the day to report which emotions they felt. Additionally, participants recorded whether they had microdosed.

The researchers hypothesized that microdosing, especially over multiple days, would increase the range of emotions experienced by participants. However, they found that on days when participants took a microdose, the overall level of emotional diversity (including both positive and negative emotions) was lower.

While microdosing did not appear to boost emotional diversity, it did appear to boost some particular emotional states.

“Turns out that microdosing doesn’t actually help people open up emotionally and allow each emotion a fair shot at the spotlight,” Pop told PsyPost. “Rather, during microdosing days, we saw specific emotions being boosted. In our study, participants experienced more ‘awe, wonder & amazement,’ but also more “‘shame & humiliation.’ Interestingly, participants also reported less ‘joy & happiness.'”

The findings raise several scientific questions that could be addressed in the future.

“It was surprising to find that certain emotions were enhanced for everyone,” Pop explained. “Further research is needed to figure out what this means. As an example, we thought each participant might experience a change in a different emotion, which would still be related to opening up. Then we generally assume that all emotions are equally relevant, but what if some are more important and so more likely to be impacted?”

“There’s also a possibility that the emotional experience is hierarchical – maybe experiencing ‘awe, wonder & amazement’ already includes experiencing ‘joy & happiness,’ which would explain why when one increased, the other decreased. Last but not least, why would ‘shame and humiliation’ spike during microdosing days?”

“It was a small study, only 18 people took part,” Pop noted. “Despite that, we collected detailed data for a month. In terms of further questions, the range of questions we can ask is so vast that it’s hard to pick a favorite. The possibilities we mentioned before could, however, give us a better idea of how microdosing psychedelics affects emotions.”

The study, “Microdosing psychedelics – Does it have an impact on emodiversity?“, was authored by Ioana Pop and Jannis Dinkelacker.

RELATED

Microdoses of LSD enhance neural complexity, study finds
Depression

Little-known psychedelic drug shows promise in treating low motivation in depression

May 9, 2025
Study finds microdosing LSD is not effective in reducing ADHD symptoms
ADHD

Study finds microdosing LSD is not effective in reducing ADHD symptoms

March 23, 2025
LSD microdosing does not appear to improve mood or cognitive ability, according to new placebo-controlled study
Microdosing

Surge in microdosing interest linked to loosened drug regulations, study finds

July 1, 2024
Neuroscience research shows psychedelics plus psychotherapy can trigger rapid brain changes
LSD

Microdosing LSD leads to longer sleep and earlier bedtimes, study finds

June 24, 2024
Psychedelic breakthrough? Microdoses of LSD show antidepressant effects in placebo-controlled study
ADHD

Psychedelic microdosing: A new frontier for treating ADHD symptoms and emotional dysregulation

May 2, 2024
Microdoses of LSD enhance neural complexity, study finds
LSD

Microdoses of LSD enhance neural complexity, study finds

April 1, 2024
Microdosing psilocybin may reduce stress-induced anhedonia
Microdosing

Microdosing psilocybin may reduce stress-induced anhedonia

January 22, 2024
Psychedelic breakthrough? Microdoses of LSD show antidepressant effects in placebo-controlled study
LSD

Psychedelic breakthrough? Microdoses of LSD show antidepressant effects in placebo-controlled study

January 18, 2024

STAY CONNECTED

LATEST

Cannabidiol shows no immediate effect on brain or behavior in young people with alcohol use disorder, study finds

From brain circuits to gut health, a new review details the complex biology of mood disorders

Attachment insecurity shapes mentalization in interracial long-distance relationships

AI detects hidden movement clues linked to Parkinson’s disease

New research complicates the story of dog domestication

Harvard scientists pinpoint how sleep stabilizes memory in fascinating neuroscience breakthrough

Surprising new findings force scientists to rethink decades of brain-plasticity theories

Breath-based meditation technique shifts brain into deeply relaxed state, study finds

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy